title: TB-HAART trial--authors' reply.
authors.affiliation: National Institute for Medical Research (NIMR), Muhumbili Centre, Tanzania.
authors.forename: Sayoki G
authors.initials: SG
authors.lastname: Mfinanga
authors.affiliation: Department of Medicine, Makerere University College of Health Sciences, Mulago Hospital, Kampala, Uganda.
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Kirenga
authors.affiliation: Institute for Medical Research & Training (IMReT), University Teaching Hospital, Lusaka, Zambia. Electronic address: duncan.chanda@gmail.com.
authors.forename: Duncan M
authors.initials: DM
authors.lastname: Chanda
authors.affiliation: Clinical Trials Unit, Medical Research Council, Durban, South Africa.
authors.forename: Cathy
authors.initials: C
authors.lastname: Connolly
authors.affiliation: Institute for Medical Research & Training (IMReT), University Teaching Hospital, Lusaka, Zambia.
authors.forename: Peter
authors.initials: P
authors.lastname: Mwaba
authors.affiliation: Supra-National TB Laboratory, Ministry of Health, Kampala, Uganda.
authors.forename: Moses
authors.initials: M
authors.lastname: Joloba
authors.affiliation: University College London, and NIHR Biomedical research centre, University College Hospitals, London, United Kingdom.
authors.forename: Alimuddin
authors.initials: A
authors.lastname: Zumla
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents